Inactive/Delisted stock

AEON Biopharma Stock (NASDAQ:AEON)

Chart

Previous Close

$0.50

52W Range

$0.38 - $269.28

50D Avg

$0.54

200D Avg

$36.29

Market Cap

$5.25M

Avg Vol (3M)

$3.24M

Beta

0.38

Div Yield

AEON Company Profile

AEON Biopharma, Inc., a biopharmaceutical company, focuses on the development botulinum toxins for the treatment of debilitating medical conditions. It also develops 900 kDabotulinum toxin complex, ABP-450, for migraine, cervical dystonia, and gastroparesis. The company was formerly known as ALPHAEON Corporation and changed its name to AEON Biopharma, Inc. in December 2019. AEON Biopharma, Inc. was incorporated in 2012 and is headquartered in Newport Beach, California.

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

Country

Employees

IPO Date

Jul 24, 2023

Website

AEON Performance

Total Return %

YTD

10Y

AEON

S&P 500

-0.96%

7.20%

23.27%

-94.69%

-98.89%

-98.75%

-99.54%

-99.93%

0.49%

4.23%

12.33%

-3.16%

0.80%

1.00%

11.68%

47.58%

100.16%

177.08%

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools